Search

Your search keyword '"Ali, Saqib"' showing total 2,121 results
Start Over Author "Ali, Saqib"
2,121 results on '"Ali, Saqib"'

15. The Impact of Social Media in Learning and Teaching: A Bibliometric-based Citation Analysis

Author

Shaikh, Abdul, Ali, Saqib, and Al-Maamari, Ramla

Subjects
Computer Science - Digital Libraries, Computer Science - Computers and Society, Computer Science - Social and Information Networks
Abstract

This paper presents the results of a systematic review of the literature on the impact of social media in learning and teaching through bibliometric based Citation analysis. The objective of the review was to map the evolution of the current literature and identify the leading sources of knowledge in terms of the most influential journals, authors, and articles. From a total of 50 top most relevant articles selected from the Scopus database, a detailed citation analysis was conducted. The study explored the overall theoretical foundation of social media research involving in learning and studying and identified the leading sources of knowledge in terms of and papers and revealed research trends over the last four years by citation analysis. The analysis of citation data showed that International Journal of Management Education is the leading journal in social media in learning and teaching research. Author Abdullah Z was found to be the leading author in this field in terms of a total number of publications, total citations, and h index, while the most cited article was authored by Baaran S. and by Bapitha L. The contribution of this study is to clearly outline the current state of knowledge regarding social media in learning and teaching services in the literature., Comment: 14 Pages

Published
2022

31. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Author

Collaborators, GBD 2019 Adolescent Young Adult Cancer, Alvarez, Elysia M, Force, Lisa M, Xu, Rixing, Compton, Kelly, Lu, Dan, Henrikson, Hannah Jacqueline, Kocarnik, Jonathan M, Harvey, James D, Pennini, Alyssa, Dean, Frances E, Fu, Weijia, Vargas, Martina T, Keegan, Theresa HM, Ariffin, Hany, Barr, Ronald D, Erdomaeva, Yana Arturovna, Gunasekera, D Sanjeeva, John-Akinola, Yetunde O, Ketterl, Tyler G, Kutluk, Tezer, Malogolowkin, Marcio Henrique, Mathur, Prashant, Radhakrishnan, Venkatraman, Ries, Lynn Ann Gloeckler, Rodriguez-Galindo, Carlos, Sagoyan, Garik Barisovich, Sultan, Iyad, Abbasi, Behzad, Abbasi-Kangevari, Mohsen, Abbasi-Kangevari, Zeinab, Abbastabar, Hedayat, Abdelmasseh, Michael, Abd-Elsalam, Sherief, Abdoli, Amir, Abebe, Haimanot, Abedi, Aidin, Abidi, Hassan, Abolhassani, Hassan, Ali, Hiwa Abubaker, Abu-Gharbieh, Eman, Achappa, Basavaprabhu, Acuna, Juan Manuel, Adedeji, Isaac Akinkunmi, Adegboye, Oyelola A, Adnani, Qorinah Estiningtyas Sakilah, Advani, Shailesh M, Afzal, Muhammad Sohail, Meybodi, Mohamad Aghaie, Ahadinezhad, Bahman, Ahinkorah, Bright Opoku, Ahmad, Sajjad, Ahmadi, Sepideh, Ahmed, Muktar Beshir, Rashid, Tarik Ahmed, Salih, Yusra Ahmed, Aiman, Wajeeha, Akalu, Gizachew Taddesse, Al Hamad, Hanadi, Alahdab, Fares, AlAmodi, Abdulhadi A, Alanezi, Fahad Mashhour, Alanzi, Turki M, Alem, Adugnaw Zeleke, Alem, Dejene Tsegaye, Alemayehu, Yosef, Alhalaiqa, Fadwa Naji, Alhassan, Robert Kaba, Ali, Saqib, Alicandro, Gianfranco, Alipour, Vahid, Aljunid, Syed Mohamed, Alkhayyat, Motasem, Alluri, Sunitha, Almasri, Nihad A, Al-Maweri, Sadeq Ali, Almustanyir, Sami, Al-Raddadi, Rajaa M, Alvis-Guzman, Nelson, Ameyaw, Edward Kwabena, Amini, Saeed, Amu, Hubert, Ancuceanu, Robert, Andrei, Catalina Liliana, Andrei, Tudorel, Ansari, Fereshteh, Ansari-Moghaddam, Alireza, Anvari, Davood, Anyasodor, Anayochukwu Edward, Arabloo, Jalal, Arab-Zozani, Morteza, Argaw, Ayele Mamo, Arshad, Muhammad, Arulappan, Judie, Aryannejad, Armin, Asemi, Zatollah, Jafarabadi, Mohammad Asghari, Atashzar, Mohammad Reza, Atorkey, and Atreya, Alok

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Pediatric, Prevention, Rare Diseases, Cancer, Burden of Illness, 2.4 Surveillance and distribution, Aetiology, Good Health and Well Being, Adolescent, Adult, Cause of Death, Disability-Adjusted Life Years, Female, Global Burden of Disease, Global Health, Humans, Incidence, Life Expectancy, Male, Mortality, Neoplasms, Prevalence, Risk Factors, Socioeconomic Factors, Young Adult, GBD 2019 Adolescent Young Adult Cancer Collaborators, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BackgroundIn estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults.MethodsUsing the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults.FindingsThere were 1·19 million (95% UI 1·11-1·28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59·6 [54·5-65·7] per 100 000 person-years) and high-middle SDI countries (53·2 [48·8-57·9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14·2 [12·9-15·6] per 100 000 person-years) and middle SDI (13·6 [12·6-14·8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23·5 million (21·9-25·2) DALYs to the global burden of disease, of which 2·7% (1·9-3·6) came from YLDs and 97·3% (96·4-98·1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally.InterpretationAdolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts.FundingBill & Melinda Gates Foundation, American Lebanese Syrian Associated Charities, St Baldrick's Foundation, and the National Cancer Institute.

Published
2022

47. New triorganotin( iv ) compounds with aromatic carboxylate ligands: synthesis and evaluation of the pro-apoptotic mechanism

Author

Rashid, Faisal, Uddin, Noor, Ali, Saqib, Haider, Ali, Tirmizi, Syed Ahmad, Diaconescu, Paula L, and Iqbal, Jamshed

Subjects
Cancer, Chemical Sciences
Abstract

Three new organotin(iv) carboxylate compounds were synthesized and structurally characterized by elemental analysis and FT-IR and multinuclear NMR (1H, 13C, 119Sn) spectroscopy. Single X-ray crystallography reveals that compound C2 has a monoclinic crystal system with space group P21/c having distorted bipyramidal geometry defined by C3SnO2. The synthesized compounds were screened for drug-DNA interactions via UV-Vis spectroscopy and cyclic voltammetry showing good activity with high binding constants. Theoretical investigations also support the reactivity of the compounds as depicted from natural bond orbital (NBO) analysis using Gaussian 09. Synthesized compounds were initially evaluated on two cancer (HeLa and MCF-7) cell lines and cytotoxicity to normal cells was evaluated using a non-cancerous (BHK-21) cell line. All the compounds were found to be active, with IC50 values less than that of the standard drug i.e. cisplatin. The cytotoxic effect of the most potent compound C2 was confirmed by LDH cytotoxicity assay and fluorescence imaging after PI staining. Apoptotic features in compound C2 treated cancer cells were visualized after DAPI staining while regulation of apoptosis was observed by reactive oxygen species generation, binding of C2 with DNA, a change in mitochondrial membrane potential and expression of activated caspase-9 and caspase-3 in cancer cells. Results are indicative of activation of the intrinsic pathway of apoptosis in C2 treated cancer cells.

Published
2021

50. Five insights from the Global Burden of Disease Study 2019

Author

Collaborators, GBD 2019 Viewpoint, Murray, Christopher JL, Abbafati, Cristiana, Abbas, Kaja M, Abbasi, Mohammad, Abbasi-Kangevari, Mohsen, Abd-Allah, Foad, Abdollahi, Mohammad, Abedi, Parisa, Abedi, Aidin, Abolhassani, Hassan, Aboyans, Victor, Abreu, Lucas Guimarães, Abrigo, Michael RM, Abu-Gharbieh, Eman, Abu Haimed, Abdulaziz Khalid, Abushouk, Abdelrahman I, Acebedo, Alyssa, Ackerman, Ilana N, Adabi, Maryam, Adamu, Abdu A, Adebayo, Oladimeji M, Adelson, Jaimie D, Adetokunboh, Olatunji O, Afarideh, Mohsen, Afshin, Ashkan, Agarwal, Gina, Agrawal, Anurag, Ahmad, Tauseef, Ahmadi, Keivan, Ahmadi, Mehdi, Ahmed, Muktar Beshir, Aji, Budi, Akinyemiju, Tomi, Akombi, Blessing, Alahdab, Fares, Alam, Khurshid, Alanezi, Fahad Mashhour, Alanzi, Turki M, Albertson, Samuel B, Alemu, Biresaw Wassihun, Alemu, Yihun Mulugeta, Alhabib, Khalid F, Ali, Muhammad, Ali, Saqib, Alicandro, Gianfranco, Alipour, Vahid, Alizade, Hesam, Aljunid, Syed Mohamed, Alla, François, Allebeck, Peter, Almadi, Majid Abdulrahman Hamad, Almasi-Hashiani, Amir, Al-Mekhlafi, Hesham M, Almulhim, Abdulaziz M, Alonso, Jordi, Al-Raddadi, Rajaa M, Altirkawi, Khalid A, Alvis-Guzman, Nelson, Amare, Bekalu, Amare, Azmeraw T, Amini, Saeed, Amit, Arianna Maever L, Amugsi, Dickson A, Anbesu, Etsay Woldu, Ancuceanu, Robert, Anderlini, Deanna, Anderson, Jason A, Andrei, Tudorel, Andrei, Catalina Liliana, Anjomshoa, Mina, Ansari, Fereshteh, Ansari-Moghaddam, Alireza, Antonio, Carl Abelardo T, Antony, Catherine M, Anvari, Davood, Appiah, Seth Christopher Yaw, Arabloo, Jalal, Arab-Zozani, Morteza, Aravkin, Aleksandr Y, Arba, Aseb Arba Kinfe, Aripov, Timur, Ärnlöv, Johan, Arowosegbe, Oluwaseyi Olalekan, Asaad, Malke, Asadi-Aliabadi, Mehran, Asadi-Pooya, Ali A, Ashbaugh, Charlie, Assmus, Michael, Atout, Maha Moh'd Wahbi, Ausloos, Marcel, Ausloos, Floriane, Quintanilla, Beatriz Paulina Ayala, Ayano, Getinet, Ayanore, Martin Amogre, Azari, Samad, Azene, Zelalem Nigussie, Darshan, BB, Babaee, Ebrahim, and Badawi, Alaa

Subjects
Prevention, 2.4 Surveillance and distribution, Aetiology, Good Health and Well Being, Birth Rate, Delivery of Health Care, Female, Global Burden of Disease, Global Health, Humans, Male, Noncommunicable Diseases, Outcome Assessment, Health Care, Risk Factors, Socioeconomic Factors, Wounds and Injuries, GBD 2019 Viewpoint Collaborators, Medical and Health Sciences, General & Internal Medicine
Abstract

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3·5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results